SFG
ARNA

SevenBridge Financial Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

SevenBridge Financial Group’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-30
Closed -$1K – 652
2017
Q3 		$1K Hold
30
– – ﹤0.01% 601
2017
Q2 		$1K Hold
30
– – ﹤0.01% 634
2017
Q1 		$0 Hold
30
– – ﹤0.01% 675
2016
Q4 		$1K Hold
30
– – ﹤0.01% 629
2016
Q3 		$1K Hold
30
– – ﹤0.01% 609
2016
Q2 		$1K Buy
+30
New +$536 ﹤0.01% 732

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SevenBridge Financial Group's ARNA Position: Q4 2017 in Review

SevenBridge Financial Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2017, closing a stake of 30 shares — an estimated $1K sold.

SevenBridge Financial Group first reported a position in ARNA in Q2 2016 and held it in 6 quarters. The position peaked at $1K in Q3 2017. 125 funds tracked by Wall St. Rank hold ARNA as of Q4 2017.

  • SevenBridge Financial Group reported no remaining Arena Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • SevenBridge Financial Group sold 30 Arena Pharmaceuticals Inc shares in Q4 2017, an estimated $1K.
  • SevenBridge Financial Group first reported a position in Arena Pharmaceuticals Inc in Q2 2016 and held it in 6 quarters.
  • SevenBridge Financial Group's Arena Pharmaceuticals Inc position peaked at $1K in Q3 2017.
  • 125 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2017.

Based on SevenBridge Financial Group's 13F filing for Q4 2017, filed 20 Feb 2018.